In a clinical trial, adding interferon treatment with a bone marrow transplant bolstered outcomes for patients with advanced, high-risk leukemia.

The effort by the Michigan Radiation Oncology Quality Consortium reduced unnecessary medical procedures, and saved the time and resources of patients and families.

Clinical guidelines have encouraged the integration of palliative care, yet medicine lags far behind its goals for ovarian cancer, especially for people of color.

The new approach blocks the interaction between cancer cells and immune receptors, showing promise in mice.

Patients with cancers of unknown origin greatly benefited from next-generation sequencing; widespread inherited cancer risk also suggests broad utility, a study finds.

A urologic oncology fellow dedicates his career to debunking false notions about racial biology.